Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Venus Remedies Ltd

NSE: VENUSREM · BSE: 526953 · Pharmaceuticals & Biotechnology · 21 announcements

Share price
₹1,769.40
Market cap
₹2,365 Cr
Revenue (annual)
₹769.6 Cr
Net profit (annual)
₹102.8 Cr
P/E (TTM)
20.4×Sector 47.3×
Promoter holding
41.76%+0.00% QoQ
FII holding
2.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:33 IST NSE
Other Announcement

Venus Remedies Other Announcement

Venus Remedies Limited has informed the exchanges about its social media posts regarding a special window for the re-lodgement of physical share transfer requests.

17:35 IST BSE
Management Change

Venus Remedies Management Change

Venus Remedies Ltd announced the appointment and re-appointment of several Directors, including Executive and Independent Directors, following approval at its 37th Annual General Meeting.

16:11 IST BSE
Annual General Meeting

Venus Remedies Annual General Meeting

Venus Remedies Ltd held its 37th Annual General Meeting on August 20, 2026, via video conferencing. The meeting addressed ordinary and special resolutions regarding company business.

17:41 IST BSE
Other Announcement

Venus Remedies Other Announcement

Venus Remedies informed the exchanges about their social media communications regarding a special window for re-lodgement of physical share transfer requests.

18:26 IST BSE
Annual General Meeting

Venus Remedies Annual General Meeting

Venus Remedies Ltd announced its 37th Annual General Meeting scheduled for August 20, 2026, to consider financial statements, dividends, and director re-appointments.

16:01 IST BSE
Board Meeting Date

Venus Remedies Board Meeting Date

Venus Remedies will hold a board meeting on July 20, 2026. The board will consider and approve unaudited financial results for the June quarter.